Cyclo Therapeutics Inc Ordinary Shares - Class A CYTH 深 沪
已收盘 10-11 16:00:00 美东时间
0.774
+0.004
+0.52%
华盛通- 最 高0.79
- 今 开0.7597
- 成交量 5.01万股
- 最 低 0.75
- 昨 收 0.77
- 总市值 2222.60万
- 52周最高 2.115
- 市盈率 静 --
- 换手率 0.17%
- 52周最低 0.5946
- 委 比 -96.37%
- 总股本 2871.57万
- 历史最高 17.75
- 量 比 1.76
- 振 幅 5.19%
- 历史最低 0.5946
- 每 手 1
- 风险率 0.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多阿尔凯默斯盘中异动 股价大涨5.01%
北京时间2024年10月12日02时35分，阿尔凯默斯（ALKS.us）股票出现波动，股价急速拉升5.01%。截至发稿，该股报28.74美元/股，成交量79....
10-12 02:35
快讯 | cyclo therapeutics与rafael holdings签署了第四份修订和重新规定的票据购买协议
Cyclo Therapeutics - Entered Into a Fourth Amended and Restated Note Purchase A...
10-09 05:16
Sonoma Pharmaceuticals, Inc.盘中异动 急速拉升5.02%报2.72美元
北京时间2024年10月09日02时01分，Sonoma Pharmaceuticals, Inc.（SNOA.us）股票出现波动，股价快速拉升5.02%。截至...
10-09 02:01
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, GATO, RFL on Behalf of Shareholders
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/o...
09-26 13:35
This Hershey Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
08-27 21:01
Maxim Group Downgrades Cyclo Therapeutics to Hold
Maxim Group analyst Jason McCarthy downgrades Cyclo Therapeutics (NASDAQ:CYTH) from Buy to Hold.
08-27 20:32
Kuehn Law Encourages CYTH, ARCH, CEIX, and VGR Investors to Contact Law Firm
NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may see...
08-26 21:37
Cyclo Therapeutics Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-23 19:20
快讯 | Cyclo Therapeutics, Inc.：H.C. Wainwright从买入降级为中立
Cyclo Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy
08-23 18:02
快讯 | Cyclo Therapeutics股票下跌28.6%，至0.90美元，与rafael holdings合并协议后
Cyclo Therapeutics Shares Down 28.6% at $0.90 After Merger Agreement With Rafae...
08-22 21:35
